{"url_path":"/sec/aidx/10-q/2026/item-7","section_key":"item-7","section_title":"Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1139685/0001213900-26-059542-index.html","accession_number":"0001213900-26-059542","cik":"0001139685","ticker":"AIDX","issuer_name":"20/20 Biolabs, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1139685/0001213900-26-059542-index.html","primary_entity_key":"0001139685","primary_entity_name":"20/20 Biolabs, Inc."},"word_count":22,"has_tables":true,"body_markdown":"Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting\nPolicies” in the Annual Report.\n\n** **\n\n8"}